Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclopol vs Propofol for FVEP Monitoring in Spine Surgery
NCT05617690Unknown
- Sponsor
- Beijing Tiantan Hospital
- Start
- Apr 2023
- Primary completion
- Dec 2024
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Randomised, double-blind trial of ciprofol (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: N75-p100 amplitude of Flash Visual Evoked Potential. Status: unknown.
02
Drugs
ciprofol
Beyond the preview
Go deeper on NCT05617690.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05617690.